15 Sep 2025 | 5 Mins Read
Alembic Pharma gets USFDA EIR for Panelav unit
Flipitmoney
Alembic Pharmaceuticals received an Establishment Inspection Report (EIR) from the USFDA post inspection at its API facility, concurrent with final approval for Phytonadione Injectable Emulsion USP and Macitentan Tablets. The firm's share price closed at Rs 945.80, 0.06% down from the previous session, with a market capitalisation of Rs 18,590.94 crore.